News

We are proud to announce that we have been shortlisted for the ‘HSJ Partnership Awards’ category at this year’s HSJ Awards, recognising work to help improve asthma care for thousands of people across our region and earning the opportunity to showcase the SENTINEL programme on a national platform.

The SENTINEL programme is being delivered in partnership with Hull University Teaching Hospitals and AstraZeneca. It aims to optimise the use of anti-inflammatory ‘preventer’ inhalers, which treat the underlying inflammation of asthma, while reducing the reliance on and prescribing of blue ‘reliever’ inhalers and the greenhouse gas emissions they produce.

The pressures faced across the healthcare sector haven’t been far from the headlines over the past 12 months – yet the quality and overriding positivity of the award entries this year highlight the enduring devotion of workers within the health and social care industry, dedicated to improving patient outcome.

A staggering 1067 entries have been received for the HSJ Awards 2022, with 219 projects and individuals making it to the final shortlist (from across 162 organisations). The high volume – and exceptional quality – of applications is once again reflecting the breadth of innovation and care within the UK’s healthcare networks.

Following the thorough judging process, Yorkshire & Humber AHSN was shortlisted, ahead of the official awards ceremony to be held later this year (November 17^th). Despite the tough competition, the SENTINEL programme really did stand out as a ‘success story’ worthy of a prized place on the panel’s shortlist. At this first stage of judging, the shortlist was based on ambition; outcome; value; involvement and working together and crucially, how the project might be “picked up” and replicated elsewhere for the benefit of both patients and professional colleagues.

Kathy Scott, Deputy CEO of Yorkshire & Humber AHSN, comments, “This really is wonderful news. To be shortlisted for the ‘HSJ Partnership Award’ amongst so many other fantastic projects is a real testament to the incredible hard work, dedication and passion of our staff and partners involved in the SENTINEL programme to improve care for thousands of people with uncontrolled asthma as well as helping the NHS to reduce its environmental impact. By adjusting how patients’ anti-inflammatory ‘preventer’ inhalers are used and reducing the reliance on and prescribing of blue ‘reliever’ inhalers, the greenhouse gas emission produced by these inhalers can be reduced.

This project is a great example of the importance of working collaboratively across healthcare organisations to help improve patient outcomes and quality of service and care for the benefit of patients across our region and beyond”.

HSJ editor Alastair McLellan, adds; “On behalf of all my colleagues, it gives me great pleasure to congratulate Yorkshire & Humber AHSN, Hull University Teaching Hospitals Trust and AstraZeneca on being shortlisted as a finalist in the category of HSJ Partnership Award. All of the applications represent the ‘very best of the NHS’ and often leave our esteemed panel of judges with an impossible choice!

“Year on year the number of entrants continue to rise which I find so encouraging and is testament to the effect that HSJ Awards can have on improved staff culture and morale.

“We’re all very much looking forward to welcoming our finalists to the awards ceremony in November, celebrating their impressive achievements and jointly acknowledging our values of sharing best practice, improving patient outcomes and continuously driving for better service. But we never forget that the award ceremony is not just a celebration within a night, but a platform to recognise the hard work of all our NHS staff, all year round.”

The full list of nominees for the 2022 HSJ awards can be found at https://awards.hsj.co.uk/ alongside details of the Awards partners; https://awards.hsj.co.uk/partners

The selected winners will be announced during the awards ceremony at the Battersea Evolution Centre, London on November 17^th 2022.